- Tailored Xenogeneic-Free Polymer Surface Promotes Dynamic Migration of Intestinal Stem Cells
- 관리자 |
- 2025-12-26 17:43:53|
- 82
ㅇ [Title] Tailored Xenogeneic-Free Polymer Surface Promotes Dynamic Migration of Intestinal Stem Cells
ㅇ [Journal] Advanced Materials
ㅇ [Author] Seonghyeon Park, Sang Yu Sun, Jin Gyeong Son, Sun Young Lee, Hyun Kyong Shon, Ohman Kwon, Minseok Lee, Keonwoo Choi, Jemin Yeun, Sung Hyun Yoon,
Minkyung Kim, Mi-Young Son,* Tae Geol Lee,* and Sung Gap Im*
ㅇ [Abstrct]
Regenerative therapy employing intestinal stem cells (ISCs) holds promise for epithelial restoration. However, it requires scalable and robust, but fully defined culture
platforms free of xenogeneic components. Most existing systems, however, typically rely on Matrigel, which complicates clinical translation and limits understanding of stem
cell-material interactions. Here, a poly(ethyleneglycoldimethacrylate) (pEGDMA)-based synthetic culture surface is exposed to N2 plasma treatment for tailored modulation
of surface properties. This modification enhances surface wettability and introduces N-containing functional groups, resulting in a PoLymer-coated Ultra-stable Surface
(PLUS) that improves ISC attachment under xenogeneic-free culture conditions. Remarkably, PLUS maintains its ISC-supportive function even after 3 years of ambient
storage. Gene expression and proteomic analyses reveal upregulation of factors involved in actin dynamics and cytoskeletal reorganization. Consistently, colonies on PLUS
exhibit a broader migratory range, with a 1.8-fold increase in migration speed compared to pristine pEGDMA. Small-molecule perturbation assays confirm the involvement of
cytoskeletal remodelling by mediating ISC-substrate interaction. Furthermore, PLUS supports dynamic, actin-dependent migration, enabling up to 46.7% wound closure
within 144 h. These findings demonstrate that PLUS engages cytoskeletal machinery as a central mediator of ISC-substrate interaction, in part by promoting actin-dependent
cytoskeletal reorganization, positioning it as a scalable, translational platform for ISC-based regenerative medicine.

| 첨부파일 |
|
|---|
